Все публикации

0:03:17

Jasmine Zain, MD, Highlights Current & Upcoming T-Cell Lymphomas Treatments

0:02:31

Michael Jordan, MD, Differentiates HLH Treatment in Pediatric Patients Versus Adults with Emapalumab

0:02:13

Germ Cell Tumors Have the Potential to Become Leukemia

0:01:52

What Makes RT001 Unique?

0:03:38

How FDA’s Breakthrough Therapy Designation Program Changed the Rare Disease Space

0:05:02

Fibrolamellar Cancer Foundation President on What’s Next for Rare Cancers

0:03:54

Addressing Diagnosis Challenges in the Rare Disease Space

0:01:54

AI: The Future for Rare Disease Treatments

0:01:30

Humility- 'The Best Characteristic in Medicine'

0:00:41

FDA Approves First Chemotherapy-Free Treatment for Waldenstrom's Macroglobulinemia

0:09:29

MDS/AML Overlap and Novel Therapies with Dr. Naval Daver

0:07:16

PNH Treatment Update

0:05:48

MDS/MPN Overlap Syndromes and Myelofibrosis

0:06:27

Treating Children with Aplastic Anemia

0:01:05

Challenges for Treating Patients with Rare Cancers

0:01:44

Molecular Events—Not Time—Define Pediatric Oncology Outcomes

0:02:20

Disparities Between Pediatric and Adult Cancers

0:01:39

A Family Affair: Multiplex Germline Testing in Melanoma

0:01:15

Efficacy of Ibrutinib and Rituximab Combination for Waldenström's Macroglobulinemia

0:01:32

Benefits of CART-T Therapies to Treat Rare Cancers

0:01:09

Team Approaches with Brain Tumors and Other Rare Cancers

0:03:50

Darcy Tannehill: AL Amyloidosis Diagnosis

0:02:53

Darcy Tannehill: Early Presentation of AL Amyloidosis

0:03:28

FCS Diet and Dangers